Autoantibodies against Endophilin A2 as a novel biomarker are beneficial to early diagnosis of breast cancer
Published: 15 September 2023| Version 2 | DOI: 10.17632/z47pry8gsw.2
This document contains the relevant clinical information and EA2 antibody test results of all breast cancer patients.
Xi'an Jiaotong University
Enzyme-Linked Immunosorbent Assay